🇺🇸 Flublok Quadrivalent in United States

387 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Headache — 50 reports (12.92%)
  2. Fall — 48 reports (12.4%)
  3. Fatigue — 48 reports (12.4%)
  4. Covid-19 — 40 reports (10.34%)
  5. Cough — 36 reports (9.3%)
  6. Pneumonia — 36 reports (9.3%)
  7. Product Dose Omission Issue — 34 reports (8.79%)
  8. Dyspnoea — 33 reports (8.53%)
  9. Sinusitis — 32 reports (8.27%)
  10. Urinary Tract Infection — 30 reports (7.75%)

Source database →

Flublok Quadrivalent in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Flublok Quadrivalent approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Flublok Quadrivalent in United States?

Fatimah Dawood is the originator. The local marketing authorisation holder may differ — check the official source linked above.